Skip to content

Diagnostic experimental study of cervical vertigo

Diagnostic experimental study of cervical vertigo

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDD-17012031
Enrollment
Unknown
Registered
2017-07-18
Start date
2017-07-19
Completion date
Unknown
Last updated
2017-07-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical dizziness

Interventions

Gold Standard:Dizziness symptoms disappeared or significantly improved after receiving ACDF
Index test:Injection&#32
of&#32
bupivacaine&#32
the&#32
degenerated&#32

Sponsors

General Hospital of Armed Police Force,
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Aged =18 years; 2) With symptoms and signs of cervical spondylotic myelopathy or cervical spondylotic myelopathy; 3) Cervical disc degeneration confirmed by MRI; 4) Accompanied by dizziness symptoms, with or without: neck pain, neck stiffness, headache, blurred vision, nausea, tinnitus and less common sense of weakness, anxiety, attention and memory and other psychological symptoms; 5) Plan to receive anterior cervical discectomy and fusion surgery; 6) Agreed to join the study and signed a written informed consent.

Exclusion criteria

Exclusion criteria: 1) Any known causes of dizziness; 2) Had received surgery for cervical spondylosis; 3) Accompanied by other spinal diseases; 4) Can not follow this research for personal reasons.

Design outcomes

Primary

MeasureTime frame
Intensity of dizziness;Frequency of dizziness;

Secondary

MeasureTime frame
mJOA score;

Countries

China

Contacts

Public ContactBaogan Peng

General Hospital of Armed Police Force

pengbaogan76611@163.com+86 13801266500

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026